Clinical Trial

Outcome of Multiple Myeloma Associated With Autoimmune Hemolytic Anemia

Name: Outcome of Multiple Myeloma Associated With Autoimmune Hemolytic Anemia — clinical trial record (NCT07354191)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed

View on ClinicalTrials.gov →

Summary

Autoimmune hemolytic anemia (AIHA) is a highly heterogeneous disease due to increased destruction of autologous erythrocytes by autoantibodies with or without complement involvement. Other pathogenic mechanisms include hyper-activation of cellular immune effectors, cytokine dysregulation, and ineffective marrow compensation.

Trial Details

NCT Number	NCT07354191
Lead Sponsor	New Valley University
Conditions	Multiple Myeloma
Enrollment	66 participants
Start Date	2023-01-15
Primary Completion	2025-11-05 (estimated)
Study Completion	2025-11-06 (estimated)
Updated on ClinicalTrials.gov	2026-01-21